(RTTNews) - Yuhan Corp. (000100.KS, 000105.KS), a South Korean pharmaceutical and chemical manufacturing company, on Wednesday reported a decline in net income despite higher sales in the third quarter of 2026 compared with the previous year.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.